Login Register Cart 0
Review Article

饮食方法在肠易激综合征中的作用

卷 26, 期 19, 2019

页: [3512 - 3520] 页: 9

弟呕挨: 10.2174/0929867324666170428102451

价格: $65

摘要

肠易激综合症（IBS）是胃肠道的一种慢性功能性疾病，是最常见的胃肠道疾病之一。 在IBS中，涉及多种病理生理机制，包括肠蠕动，通透性，营养吸收和肠微生物群的改变。 患者通常认为食物是引起症状的诱因，因此很可能与IBS中症状的产生有关。 在所有可能的治疗选择中，IBS的一线治疗方法是饮食教育和识别可能引起症状发作或恶化的食品。 饮食方法包括减少产气食品（即可发酵的寡糖，二糖以及单糖和多元醇（FODMAP）），乳糖和面筋。 需要进行进一步的研究以将饮食在不同IBS亚型中的最终作用联系起来。

关键词: 饮食，胃肠功能紊乱，FODMAP，肠道菌群，IBS，产气食品。

« Previous Next »
[1]
Longstreth, G.F.; Thompson, W.G.; Chey, W.D.; Houghton, L.A.; Mearin, F.; Spiller, R.C. Functional bowel disorders. Gastroenterology, 2006, 130(5), 1480-1491.
[http://dx.doi.org/10.1053/j.gastro.2005.11.061] [PMID: 16678561]
[2]
Lovell, R.M.; Ford, A.C. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin. Gastroenterol. Hepatol., 2012, 10, 712-721.e714.
[http://dx.doi.org/10.1016/j.cgh.2012.02.029] [PMID: 22426087]
[3]
Halder, S.L.; Locke, G.R., III; Schleck, C.D.; Zinsmeister, A.R.; Melton, L.J., III; Talley, N.J. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology, 2007, 133(3), 799-807.
[http://dx.doi.org/10.1053/j.gastro.2007.06.010] [PMID: 17678917]
[4]
Ford, A.C.; Forman, D.; Bailey, A.G.; Axon, A.T.; Moayyedi, P. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am. J. Gastroenterol., 2008, 103(5), 1229-1239.
[http://dx.doi.org/10.1111/j.1572-0241.2007.01740.x] [PMID: 18371141]
[5]
Camilleri, M.; Heading, R.C.; Thompson, W.G. Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment. Pharmacol. Ther., 2002, 16(8), 1407-1430.
[http://dx.doi.org/10.1046/j.1365-2036.2002.01305.x] [PMID: 12182741]
[6]
Drossman, D.A.; Camilleri, M.; Mayer, E.A.; Whitehead, W.E. AGA technical review on irritable bowel syndrome. Gastroenterology, 2002, 123(6), 2108-2131.
[http://dx.doi.org/10.1053/gast.2002.37095] [PMID: 12454866]
[7]
Peery, A.F.; Dellon, E.S.; Lund, J.; Crockett, S.D.; McGowan, C.E.; Bulsiewicz, W.J.; Gangarosa, L.M.; Thiny, M.T.; Stizenberg, K.; Morgan, D.R.; Ringel, Y.; Kim, H.P.; Dibonaventura, M.D.; Carroll, C.F.; Allen, J.K.; Cook, S.F.; Sandler, R.S.; Kappelman, M.D.; Shaheen, N.J. Burden of gastrointestinal disease in the United States: 2012 update Gastroenterology,, 2012, 43, 1179-1187.e1171-1173.
[8]
Mearin, F.; Lacy, B.E.; Chang, L.; Chey, W.D.; Lembo, A.J.; Simren, M.; Spiller, R. Bowel disorders. Gastroenterology, 2016, 150, 1393-1407.e1395.
[http://dx.doi.org/10.1053/j.gastro.2016.02.031] [PMID: 27144627]
[9]
Heaton, K.W.; O’Donnell, L.J.D. An office guide to whole-gut transit time. Patients’ recollection of their stool form. J. Clin. Gastroenterol., 1994, 19(1), 28-30.
[http://dx.doi.org/10.1097/00004836-199407000-00008] [PMID: 7930429]
[10]
Lewis, S.J.; Heaton, K.W. Stool form scale as a useful guide to intestinal transit time. Scand. J. Gastroenterol., 1997, 32(9), 920-924.
[http://dx.doi.org/10.3109/00365529709011203] [PMID: 9299672]
[11]
Mearin, F.; Lacy, B.E.; Chang, L.; Chey, W.D.; Lembo, A.J.; Simren, M.; Spiller, R. Bowel disorders. Gastroenterology, 2016, S0016-5085.(16)00222-5.
[http://dx.doi.org/10.1053/j.gastro.2016.02.031] [PMID: 27144627]
[12]
Camilleri, M.; Lasch, K.; Zhou, W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol., 2012, 303(7), G775-G785.
[http://dx.doi.org/10.1152/ajpgi.00155.2012] [PMID: 22837345]
[13]
Camilleri, M. Peripheral mechanisms in irritable bowel syndrome. N. Engl. J. Med., 2012, 367(17), 1626-1635.
[http://dx.doi.org/10.1056/NEJMra1207068] [PMID: 23094724]
[14]
Bonfrate, L.; Tack, J.; Grattagliano, I.; Cuomo, R.; Portincasa, P. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand. J. Gastroenterol., 2013, 48(9), 995-1009.
[http://dx.doi.org/10.3109/00365521.2013.799220] [PMID: 23964766]
[15]
Whitehead, W.E.; Holtkotter, B.; Enck, P.; Hoelzl, R.; Holmes, K.D.; Anthony, J.; Shabsin, H.S.; Schuster, M.M. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology, 1990, 98(5 Pt 1), 1187-1192.
[http://dx.doi.org/10.1016/0016-5085(90)90332-U] [PMID: 2323511]
[16]
Bouin, M.; Plourde, V.; Boivin, M.; Riberdy, M.; Lupien, F.; Laganière, M.; Verrier, P.; Poitras, P. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology, 2002, 122(7), 1771-1777.
[http://dx.doi.org/10.1053/gast.2002.33601] [PMID: 12055583]
[17]
Zuo, X.L.; Li, Y.Q.; Shi, L.; Lv, G.P.; Kuang, R.G.; Lu, X.F.; Li, J.M.; Desmond, P.V. Visceral hypersensitivity following cold water intake in subjects with irritable bowel syndrome. J. Gastroenterol., 2006, 41(4), 311-317.
[http://dx.doi.org/10.1007/s00535-005-1766-x] [PMID: 16741609]
[18]
Nozu, T.; Kudaira, M.; Kitamori, S.; Uehara, A. Repetitive rectal painful distention induces rectal hypersensitivity in patients with irritable bowel syndrome. J. Gastroenterol., 2006, 41(3), 217-222.
[http://dx.doi.org/10.1007/s00535-005-1748-z] [PMID: 16699855]
[19]
Schmidt, T.; Hackelsberger, N.; Widmer, R.; Meisel, C.; Pfeiffer, A.; Kaess, H. Ambulatory 24-hour jejunal motility in diarrhea-predominant irritable bowel syndrome. Scand. J. Gastroenterol., 1996, 31(6), 581-589.
[http://dx.doi.org/10.3109/00365529609009131] [PMID: 8789897]
[20]
Kumar, D.; Wingate, D. Irritable bowel syndrome: a paroxysmal motor disorder. Lancet, 1986, 1(8481), 620-621.
[http://dx.doi.org/10.1016/S0140-6736(86)92846-1] [PMID: 2869331]
[21]
Simrén, M.; Castedal, M.; Svedlund, J.; Abrahamsson, H.; Björnsson, E. Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS) [correction of (IBD)] Dig. Dis. Sci., 2000, 45(11), 2151-2161.
[http://dx.doi.org/10.1023/A:1010770302403] [PMID: 11215731]
[22]
Portincasa, P.; Moschetta, A.; Baldassarre, G.; Altomare, D.F.; Palasciano, G. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J. Gastroenterol., 2003, 9(10), 2293-2299.
[http://dx.doi.org/10.3748/wjg.v9.i10.2293] [PMID: 14562396]
[23]
Marshall, J.K.; Thabane, M.; Borgaonkar, M.R.; James, C. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin. Gastroenterol. Hepatol., 2007, 5(4), 457-460.
[http://dx.doi.org/10.1016/j.cgh.2006.11.025] [PMID: 17289440]
[24]
Marshall, J.K.; Thabane, M.; Garg, A.X.; Clark, W.F.; Salvadori, M.; Collins, S.M. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology, 2006, 131(2), 445-450.
[http://dx.doi.org/10.1053/j.gastro.2006.05.053] [PMID: 16890598]
[25]
Thabane, M.; Kottachchi, D.T.; Marshall, J.K. Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment. Pharmacol. Ther., 2007, 26(4), 535-544.
[http://dx.doi.org/10.1111/j.1365-2036.2007.03399.x] [PMID: 17661757]
[26]
Halvorson, H.A.; Schlett, C.D.; Riddle, M.S. Postinfectious irritable bowel syndrome--a meta-analysis. Am. J. Gastroenterol., 2006, 101(8), 1894-1899.
[http://dx.doi.org/10.1111/j.1572-0241.2006.00654.x] [PMID: 16928253]
[27]
Chadwick, V.S.; Chen, W.; Shu, D.; Paulus, B.; Bethwaite, P.; Tie, A.; Wilson, I. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology, 2002, 122(7), 1778-1783.
[http://dx.doi.org/10.1053/gast.2002.33579] [PMID: 12055584]
[28]
Liebregts, T.; Adam, B.; Bredack, C.; Röth, A.; Heinzel, S.; Lester, S.; Downie-Doyle, S.; Smith, E.; Drew, P.; Talley, N.J.; Holtmann, G. Immune activation in patients with irritable bowel syndrome. Gastroenterology, 2007, 132(3), 913-920.
[http://dx.doi.org/10.1053/j.gastro.2007.01.046] [PMID: 17383420]
[29]
Saito, Y.A.; Petersen, G.M.; Locke, G.R., III; Talley, N.J. The genetics of irritable bowel syndrome. Clin. Gastroenterol. Hepatol., 2005, 3(11), 1057-1065.
[http://dx.doi.org/10.1016/S1542-3565(05)00184-9] [PMID: 16271334]
[30]
Beyder, A.; Mazzone, A.; Strege, P.R.; Tester, D.J.; Saito, Y.A.; Bernard, C.E.; Enders, F.T.; Ek, W.E.; Schmidt, P.T.; Dlugosz, A.; Lindberg, G.; Karling, P.; Ohlsson, B.; Gazouli, M.; Nardone, G.; Cuomo, R.; Usai-Satta, P.; Galeazzi, F.; Neri, M.; Portincasa, P.; Bellini, M.; Barbara, G.; Camilleri, M.; Locke, G.R., III; Talley, N.J.; D’Amato, M.; Ackerman, M.J.; Farrugia, G. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. Gastroenterology, 2014, 146(7), 1659-1668.
[http://dx.doi.org/10.1053/j.gastro.2014.02.054] [PMID: 24613995]
[31]
Chang, L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology, 2011, 140(3), 761-765.
[http://dx.doi.org/10.1053/j.gastro.2011.01.032] [PMID: 21256129]
[32]
Kassinen, A.; Krogius-Kurikka, L.; Mäkivuokko, H.; Rinttilä, T.; Paulin, L.; Corander, J.; Malinen, E.; Apajalahti, J.; Palva, A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology, 2007, 133(1), 24-33.
[http://dx.doi.org/10.1053/j.gastro.2007.04.005] [PMID: 17631127]
[33]
Malinen, E.; Rinttilä, T.; Kajander, K.; Mättö, J.; Kassinen, A.; Krogius, L.; Saarela, M.; Korpela, R.; Palva, A. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol., 2005, 100(2), 373-382.
[http://dx.doi.org/10.1111/j.1572-0241.2005.40312.x] [PMID: 15667495]
[34]
Rajilić-Stojanović, M.; Biagi, E.; Heilig, H.G.; Kajander, K.; Kekkonen, R.A.; Tims, S.; de Vos, W.M. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology, 2011, 141(5), 1792-1801.
[http://dx.doi.org/10.1053/j.gastro.2011.07.043] [PMID: 21820992]
[35]
Saulnier, D.M.; Riehle, K.; Mistretta, T.A.; Diaz, M.A.; Mandal, D.; Raza, S.; Weidler, E.M.; Qin, X.; Coarfa, C.; Milosavljevic, A.; Petrosino, J.F.; Highlander, S.; Gibbs, R.; Lynch, S.V.; Shulman, R.J.; Versalovic, J. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology, 2011, 141(5), 1782-1791.
[http://dx.doi.org/10.1053/j.gastro.2011.06.072] [PMID: 21741921]
[36]
Jeffery, I.B.; O’Toole, P.W.; Öhman, L.; Claesson, M.J.; Deane, J.; Quigley, E.M.; Simrén, M. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut, 2012, 61(7), 997-1006.
[http://dx.doi.org/10.1136/gutjnl-2011-301501] [PMID: 22180058]
[37]
Bischoff, S.C.; Barbara, G.; Buurman, W.; Ockhuizen, T.; Schulzke, J-D.; Serino, M.; Tilg, H.; Watson, A.; Wells, J.M. Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol., 2014, 14, 189.
[http://dx.doi.org/10.1186/s12876-014-0189-7] [PMID: 25407511]
[38]
Simrén, M.; Barbara, G.; Flint, H.J.; Spiegel, B.M.; Spiller, R.C.; Vanner, S.; Verdu, E.F.; Whorwell, P.J.; Zoetendal, E.G. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut, 2013, 62(1), 159-176.
[http://dx.doi.org/10.1136/gutjnl-2012-302167] [PMID: 22730468]
[39]
Mättö, J.; Maunuksela, L.; Kajander, K.; Palva, A.; Korpela, R.; Kassinen, A.; Saarela, M. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects. FEMS Immunol. Med. Microbiol., 2005, 43(2), 213-222.
[http://dx.doi.org/10.1016/j.femsim.2004.08.009] [PMID: 15747442]
[40]
Ford, A.C.; Moayyedi, P.; Lacy, B.E.; Lembo, A.J.; Saito, Y.A.; Schiller, L.R.; Soffer, E.E.; Spiegel, B.M.; Quigley, E.M. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am. J. Gastroenterol., 2014, 109(Suppl. 1), S2-S26.
[http://dx.doi.org/10.1038/ajg.2014.187] [PMID: 25091148]
[41]
Kaptchuk, T.J.; Kelley, J.M.; Conboy, L.A.; Davis, R.B.; Kerr, C.E.; Jacobson, E.E.; Kirsch, I.; Schyner, R.N.; Nam, B.H.; Nguyen, L.T.; Park, M.; Rivers, A.L.; McManus, C.; Kokkotou, E.; Drossman, D.A.; Goldman, P.; Lembo, A.J. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ, 2008, 336(7651), 999-1003.
[http://dx.doi.org/10.1136/bmj.39524.439618.25] [PMID: 18390493]
[42]
Drossman, D.A.; Thompson, W.G. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann. Intern. Med., 1992, 116(12 Pt 1), 1009-1016.
[http://dx.doi.org/10.7326/0003-4819-116-12-1009] [PMID: 1586090]
[43]
Owens, D.M.; Nelson, D.K.; Talley, N.J. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann. Intern. Med., 1995, 122(2), 107-112.
[http://dx.doi.org/10.7326/0003-4819-122-2-199501150-00005] [PMID: 7992984]
[44]
Halpert, A.; Dalton, C.B.; Palsson, O.; Morris, C.; Hu, Y.; Bangdiwala, S.; Hankins, J.; Norton, N.; Drossman, D.A. Irritable bowel syndrome patients’ ideal expectations and recent experiences with healthcare providers: a national survey. Dig. Dis. Sci., 2010, 55(2), 375-383.
[http://dx.doi.org/10.1007/s10620-009-0855-8] [PMID: 19513835]
[45]
Simrén, M.; Månsson, A.; Langkilde, A.M.; Svedlund, J.; Abrahamsson, H.; Bengtsson, U.; Björnsson, E.S. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion, 2001, 63(2), 108-115.
[http://dx.doi.org/10.1159/000051878] [PMID: 11244249]
[46]
Monsbakken, K.W.; Vandvik, P.O.; Farup, P.G. Perceived food intolerance in subjects with irritable bowel syndrome-- etiology, prevalence and consequences. Eur. J. Clin. Nutr., 2006, 60(5), 667-672.
[http://dx.doi.org/10.1038/sj.ejcn.1602367] [PMID: 16391571]
[47]
Gasbarrini, A.; Corazza, G.R.; Gasbarrini, G.; Montalto, M.; Di Stefano, M.; Basilisco, G.; Parodi, A.; Usai-Satta, P.; Vernia, P.; Anania, C.; Astegiano, M.; Barbara, G.; Benini, L.; Bonazzi, P.; Capurso, G.; Certo, M.; Colecchia, A.; Cuoco, L.; Di Sario, A.; Festi, D.; Lauritano, C.; Miceli, E.; Nardone, G.; Perri, F.; Portincasa, P.; Risicato, R.; Sorge, M.; Tursi, A. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment. Pharmacol. Ther., 2009, 29(Suppl. 1), 1-49.
[http://dx.doi.org/10.1111/j.1365-2036.2009.03951.x] [PMID: 19344474]
[48]
Bonfrate, L.; Krawczyk, M.; Lembo, A.; Grattagliano, I.; Lammert, F.; Portincasa, P. Effects of dietary education, followed by a tailored fructose-restricted diet in adults with fructose malabsorption. Eur. J. Gastroenterol. Hepatol., 2015, 27(7), 785-796.
[http://dx.doi.org/10.1097/MEG.0000000000000374] [PMID: 25919770]
[49]
Zhu, Y.; Zheng, X.; Cong, Y.; Chu, H.; Fried, M.; Dai, N.; Fox, M. Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency. Am. J. Gastroenterol., 2013, 108(9), 1516-1525.
[http://dx.doi.org/10.1038/ajg.2013.198] [PMID: 23917444]
[50]
Yang, J.; Deng, Y.; Chu, H.; Cong, Y.; Zhao, J.; Pohl, D.; Misselwitz, B.; Fried, M.; Dai, N.; Fox, M.; Yang, J.; Deng, Y.; Chu, H.; Cong, Y.; Zhao, J.; Pohl, D.; Misselwitz, B.; Fried, M.; Dai, N.; Fox, M. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. PClin Gastroenterol Hepatol, 2013, 11, 262-268.e261.
[http://dx.doi.org/10.1016/j.cgh.2012.11.034]
[51]
Krawczyk, M.; Wolska, M.; Schwartz, S.; Gruenhage, F.; Terjung, B.; Portincasa, P.; Sauerbruch, T.; Lammert, F. Concordance of genetic and breath tests for lactose intolerance in a tertiary referral centre. J. Gastrointestin. Liver Dis., 2008, 17(2), 135-139.
[PMID: 18568133]
[52]
S.; Brandt, L.J.; Chey, W.D.; Foxx-Orenstein, A.E.; Schiller, L.R.; Schoenfeld, P.S.; Spiegel, B.M.; Talley, N.J.; Quigley, E.M. An evidence-based position statement on the management of irritable bowel syndrome. Am. J. Gastroenterol., 2009, 104(Suppl. 1), S1-S35.
[53]
Böhmer, C.J.; Tuynman, H.A. The effect of a lactose-restricted diet in patients with a positive lactose tolerance test, earlier diagnosed as irritable bowel syndrome: a 5-year follow-up study. Eur. J. Gastroenterol. Hepatol., 2001, 13(8), 941-944.
[http://dx.doi.org/10.1097/00042737-200108000-00011] [PMID: 11507359]
[54]
Portincasa, P.; Di Ciaula, A.; Vacca, M.; Montelli, R.; Wang, D.Q.; Palasciano, G. Beneficial effects of oral tilactase on patients with hypolactasia. Eur. J. Clin. Invest., 2008, 38(11), 835-844.
[http://dx.doi.org/10.1111/j.1365-2362.2008.02035.x] [PMID: 19021701]
[55]
Shepherd, S.J.; Lomer, M.C.; Gibson, P.R. Short-chain carbohydrates and functional gastrointestinal disorders. Am. J. Gastroenterol., 2013, 108(5), 707-717.
[http://dx.doi.org/10.1038/ajg.2013.96] [PMID: 23588241]
[56]
Ong, D.K.; Mitchell, S.B.; Barrett, J.S.; Shepherd, S.J.; Irving, P.M.; Biesiekierski, J.R.; Smith, S.; Gibson, P.R.; Muir, J.G. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J. Gastroenterol. Hepatol., 2010, 25(8), 1366-1373.
[http://dx.doi.org/10.1111/j.1440-1746.2010.06370.x] [PMID: 20659225]
[57]
Gibson, P.R.; Shepherd, S. J. Personal view: food for thought--western lifestyle and susceptibility to Crohn’s disease. The FODMAP hypothesis. Aliment. Pharmacol. Ther., 2005, 21(12), 1399-1409.
[http://dx.doi.org/10.1111/j.1365-2036.2005.02506.x] [PMID: 15948806]
[58]
Moayyedi, P.; Quigley, E.M.; Lacy, B.E.; Lembo, A.J.; Saito, Y.A.; Schiller, L.R.; Soffer, E.E.; Spiegel, B.M.; Ford, A.C. The effect of dietary intervention on irritable bowel syndrome: a systematic review. Clin. Transl. Gastroenterol, 2015, 6e107.
[http://dx.doi.org/10.1038/ctg.2015.21] [PMID: 26291435]
[59]
Shepherd, S.J.; Parker, F.C.; Muir, J.G.; Gibson, P.R. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin. Gastroenterol. Hepatol., 2008, 6(7), 765-771.
[http://dx.doi.org/10.1016/j.cgh.2008.02.058] [PMID: 18456565]
[60]
Halmos, E.P.; Power, V.A.; Shepherd, S.J.; Gibson, P.R.; Muir, J.G. A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome. Gastroenterology, 2014, 146, 67-75.e65.
[http://dx.doi.org/10.1053/j.gastro.2013.09.046] [PMID: 24076059]
[61]
Bohn, L.; Storsrud, S.; Liljebo, T.; Collin, L.; Lindfors, P.; Tornblom, H.; Simren, M. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology, 2015, 149(6), 1399-1407.e2.
[http://dx.doi.org/10.1053/j.gastro.2015.07.054] [PMID: 26255043]
[62]
McKenzie, Y.A.; Alder, A.; Anderson, W.; Wills, A.; Goddard, L.; Gulia, P.; Jankovich, E.; Mutch, P.; Reeves, L.B.; Singer, A.; Lomer, M.C. British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults. J. Hum. Nutr. Diet., 2012, 25(3), 260-274.
[http://dx.doi.org/10.1111/j.1365-277X.2012.01242.x] [PMID: 22489905]
[63]
Rao, S.S.C.; Yu, S.; Fedewa, A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment. Pharmacol. Ther., 2015, 41(12), 1256-1270.
[http://dx.doi.org/10.1111/apt.13167] [PMID: 25903636]
[64]
Verdu, E.F.; Huang, X.; Natividad, J.; Lu, J.; Blennerhassett, P.A.; David, C.S.; McKay, D.M.; Murray, J.A. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am. J. Physiol. Gastrointest. Liver Physiol., 2008, 294(1), G217-G225.
[http://dx.doi.org/10.1152/ajpgi.00225.2007] [PMID: 18006603]
[65]
Vazquez-Roque, M.I.; Camilleri, M.; Smyrk, T.; Murray, J.A.; Marietta, E.; O’Neill, J.; Carlson, P.; Lamsam, J.; Janzow, D.; Eckert, D.; Burton, D.; Zinsmeister, A.R. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology, 2013, 144, 903-911.e903.
[http://dx.doi.org/10.1053/j.gastro.2013.01.049] [PMID: 23357715]
[66]
Biesiekierski, J.R.; Newnham, E.D.; Irving, P.M.; Barrett, J.S.; Haines, M.; Doecke, J.D.; Shepherd, S.J.; Muir, J.G.; Gibson, P.R. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am. J. Gastroenterol., 2011, 106(3), 508-514.
[http://dx.doi.org/10.1038/ajg.2010.487] [PMID: 21224837]
[67]
Biesiekierski, J.R.; Peters, S.L.; Newnham, E.D.; Rosella, O.; Muir, J.G.; Gibson, P.R. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology,, 2013, 145(2), 320-8.e1-3.
[http://dx.doi.org/10.1053/j.gastro.2013.04.051] [PMID: 23648697]
[68]
Drossman, D.A.; Whitehead, W.E.; Camilleri, M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology, 1997, 112(6), 2120-2137.
[http://dx.doi.org/10.1053/gast.1997.v112.agast972120] [PMID: 9178709]
[69]
Ford, A.C.; Talley, N.J. Irritable bowel syndrome BMJ,, 2012, 345, e5836..
[http://dx.doi.org/10.1136/bmj.e5836] [PMID: 22951548]
[70]
Ruepert, L.; Quartero, A.O.; de Wit, N.J.; van der Heijden, G.J.; Rubin, G.; Muris, J.W. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst. Rev., 2011, (8)CD003460
[http://dx.doi.org/10.1002/14651858.CD003460.pub3] [PMID: 21833945]
[71]
Ford, A.C.; Talley, N.J.; Spiegel, B.M.; Foxx-Orenstein, A.E.; Schiller, L.; Quigley, E.M.; Moayyedi, P. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ, 2008, 337, a2313.
[http://dx.doi.org/10.1136/bmj.a2313] [PMID: 19008265]
[72]
Gupta, S.C.; Kismali, G.; Aggarwal, B.B. Curcumin, a component of turmeric: from farm to pharmacy. Biofactors, 2013, 39(1), 2-13.
[http://dx.doi.org/10.1002/biof.1079] [PMID: 23339055]
[73]
Portincasa, P.; Bonfrate, L.; Scribano, M.L.; Kohn, A.; Caporaso, N.; Festi, D.; Campanale, M.C.; Di Rienzo, T.; Guarino, M.; Taddia, M.; Fogli, M.V.; Grimaldi, M.; Gasbarrini, A. Curcumin and fennel essential oil improve symptoms and quality of life in patients with irritable bowel syndrome. J. Gastrointestin. Liver Dis., 2016, 25(2), 151-157.
[http://dx.doi.org/dx. doi: 10.15403/jgld.2014.1121.252.ccm] [PMID: 27308645]
[74]
Lang, A.; Salomon, N.; Wu, J.C.; Kopylov, U.; Lahat, A.; Har-Noy, O.; Ching, J.Y.; Cheong, P.K.; Avidan, B.; Gamus, D.; Kaimakliotis, I.; Eliakim, R.; Ng, S.C.; Ben-Horin, S. Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Gastroenterol. Hepatol., 2015, 13, 1444-1449.e1441..
[http://dx.doi.org/10.1016/j.cgh.2015.02.019] [PMID: 25724700]
[75]
Atkinson, W.; Sheldon, T.A.; Shaath, N.; Whorwell, P.J. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut, 2004, 53(10), 1459-1464.
[http://dx.doi.org/10.1136/gut.2003.037697] [PMID: 15361495]

Rights & Permissions Print Cite
Article Metrics
48
4
Wayfinder Image
World Antimicrobial Awareness Week
© 2024 Bentham Science Publishers | Privacy Policy